GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025
GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide
GE HealthCare showcases commitment to sustainable innovation at RSNA 2024
GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI
GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024
GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care
GE HealthCare management to present at upcoming investor conferences
GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology
